67
Participants
Start Date
September 30, 2002
Primary Completion Date
March 31, 2009
Study Completion Date
December 31, 2011
Dalteparin sodium injection
200units/kg subcutaneous daily for one month, followed by 150units/kg subcutaneous daily for two additional months or 200 units/kg subcutaneously daily for 5 days followed by warfarin.
Warfarin
Titrated to INR 2-3 through study month 3
Department of Veterans Affairs Medical Center, Oklahoma City
University of Oklahoma Health Science Center, Oklahoma City
Collaborators (1)
Pfizer
INDUSTRY
University of Oklahoma
OTHER